Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
Мақола

Glycyrrhizic Acid Monoammonium Complex (XF-2): Chemical Profile and Immunomodulatory Evaluation

Fayyoza KhurramovaA.S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Tashkent, UzbekistanR. S. EsanovNational University of Uzbekistan, Tashkent, UzbekistanIzzatullo AbdullaevA.S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Tashkent, UzbekistanUlugbek GayibovA.S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Tashkent, UzbekistanKuralbay Zhadigerovich RezhepovA.S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Tashkent, UzbekistanAlimjan MatchanovA.S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Tashkent, Uzbekistan
Trends in Sciencesjournal2026
ABI

Аннотация

This study explores the physicochemical and biological properties of the supramolecular complex XF-2, composed of glycyrrhizic acid monoammonium salt and anti-tuberculosis drugs pyrazinamide, isoniazid, rifampicin, and levofloxacin. UV-Vis spectroscopy revealed a bathochromic shift from 254 to 264 nm, confirming electronic interactions between glycyrrhizic acid and the guest molecules. FTIR spectra showed characteristic bands at 1,658 cm⁻¹ (C=O) and 1,593 cm⁻¹ (–COO⁻), indicating ionic and hydrogen-bonded interactions responsible for supramolecular assembly formation. Molecular docking analysis demonstrated stable binding of XF-2 components with NF-κB p52 (2AZ5), IL-10 (1VLK), and IL-6 receptor (1A3Q), with binding energies ranging from –4.6 to –9.2 kcal/mol. Rifampicin and levofloxacin exhibited the strongest affinities, forming multiple hydrogen bonds, π-π stacking, and electrostatic interactions with key amino acid residues. In vivo studies showed that XF-2 is low-toxic (LD₅₀ = 4,050 mg/kg) and exerts marked immunomodulatory activity in prednisolone-induced immunosuppressed mice. At 1,000 mg/kg, the complex significantly increased thymus and spleen indices, restoring immune organ weights close to normal values. Together, spectroscopic, computational, and pharmacological data confirm that XF-2 is a stable, safe, and biologically active supramolecular formulation with strong immunorestorative potential, making it a promising candidate for further development as an immunomodulatory and protective agent. HIGHLIGHTS The supramolecular complex XF-2 was formed with glycyrrhizic acid monoammonium salt. UV-Vis and FTIR spectra confirmed hydrogen-bonded and ionic complex formation. Docking showed strong binding to NF-κB p52, IL-10, and IL-6 receptor proteins. XF-2 exhibited low acute toxicity (LD₅₀ = 4050 mg/kg) in in vivo preclinical tests. The complex restored thymus and spleen indices, showing potent immunomodulatory activity. GRAPHICAL ABSTRACT

Ҳали таржима қилинмаган

Мавзулар

Идентификаторлар

Иқтибослар ва манбалар

0 та иқтибос0 та фойдаланилган манба